FibroBiologics, Inc. (FBLG)
NGM · Common · CUSIP 31573L105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for FBLG and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
31573L105
Business: FibroBiologics, Inc. is a cell therapy and regenerative medicine company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds over 150 US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, wound healing, reversing organ involution, and cancer.

Company Contact

CEO
Pete O’Heeron
CFO
Jason D. Davis
Headquarters
455 E. Medical Center Blvd, Suite 300, Houston, TX 77598
Phone
281-651-5150
Investor Relations
Nic Johnson, Russo Partners · 212-845-4242 · fibrobiologicsIR@russopr.com
SEC EDGAR Filings
View filings »